Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Puretech Health Plc ADR
(NQ:
PRTC
)
22.53
UNCHANGED
Streaming Delayed Price
Updated: 11:09 AM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Puretech Health Plc ADR
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Friday's Intraday Session
December 22, 2023
Via
Benzinga
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday
December 22, 2023
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sharply during Friday’s session following acquisition...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
December 22, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Year End Update and Outlook for 2024
December 20, 2023
From
PureTech Health plc
Via
Business Wire
ZimVie Agrees To Sell Its Spine Business, Joins United States Steel, PGT Innovations And Other Big Stocks Moving Higher On Monday
December 18, 2023
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 30 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023
December 07, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
November 29, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
November 17, 2023
From
PureTech Health plc
Via
Business Wire
PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers
November 14, 2023
From
PureTech Health plc
Via
Business Wire
PureTech to Present at Two Upcoming Investor Conferences
October 17, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting
October 11, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation
October 04, 2023
From
PureTech Health plc
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 03, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
KarXT, invented at PureTech, submitted for FDA Approval in Schizophrenia
September 28, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Announces the Appointment of Robert Lyne as Chief Portfolio Officer
September 27, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Health plc – Half-Year Report
August 29, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Half-Yearly Results
August 22, 2023
From
PureTech Health plc
Via
Business Wire
Marijuana Stock Movers For August 2, 2023
August 02, 2023
Via
Benzinga
PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome
August 01, 2023
From
PureTech Health plc
Via
Business Wire
This Emerging Market Could Be the Next Big Thing in Biotech
July 14, 2023
Medicines to treat the many symptoms of long COVID are in high demand already.
Via
The Motley Fool
PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders
June 21, 2023
From
PureTech Health plc
Via
Business Wire
Results of PureTech's Annual General Meeting
June 13, 2023
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Jefferies Healthcare Conference
May 24, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week
May 09, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
May 04, 2023
From
PureTech Health plc
Via
Business Wire
PureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The Details
April 28, 2023
PureTech Health plc (NASDAQ: PRTC) (LSE:PRTC) released its results for the year ended December 31, 2022, revealing revenue of $15.6 million, a decrease of 10.2% compared to $17.4 million in 2021....
Via
Benzinga
PureTech Announces Annual Results for Year Ended December 31, 2022
April 28, 2023
From
PureTech Health plc
Via
Business Wire
Earnings Scheduled For April 28, 2023
April 28, 2023
Companies Reporting Before The Bell • GrafTech International (NYSE:EAF) is likely to report quarterly loss at $0.01 per share on revenue of $123.00 million.
Via
Benzinga
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
April 25, 2023
From
PureTech Health plc
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.